Sophia Zoungas's Publications

Zoungas Sophia
Severe hypoglycemia and risks of vascular events and death in the ADVANCE trial
Conference Paper
2010
American Diabetes Association, Late Breaking Clinical Studies
Li Qiang, Grobbee D., Ninomiya T., de Galan Bastiaan, Kengne Andre, Woodward Mark, Zoungas Sophia, Marre M., Heller S., Chalmers J.
Severe hypoglycemia and risks of vascular events and death
Journal Article
2010
New England Journal of Medicine
Zoungas Sophia
Intensive glucose control is renoprotective in type 2 diabetes
Conference Paper
2010
European Association for the Study of Diabetes
Heerspink H., Ninomiya T., Turnbull Fiona, Cass Alan, Zoungas Sophia, Zanchetti A., Gallagher M., Jardine M, Chalmers J., Perkovic Vlado
Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population
Conference Proceedings
2010
46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology
Razavian M., Cass Alan, Weekes A., Heeley Emma, Zoungas Sophia, Anderson Craig, Chalmers J., Perkovic Vlado, Patel Anushka
Management of chronic kidney disease in Australian general practice (the AusHEART Study)
Conference Proceedings
2010
46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology
Zoungas Sophia, Webster A., Jun M., Perkovic Vlado
How to read a report of a randomized controlled trial
Journal Article
2010
Nephrology (Carlton)
Zoungas Sophia
Chronic Kidney Disease and Cardiovascular risk (Co Chair of session entitled “Bones, Hearts and Kidneys”) [Invited speaker]
Conference Paper
2010
World Congress of Internal Medicine
Kengne Andre, Zoungas Sophia, Grobbee R., Marre M., Poulter N., Colagiuri S., Hamet P., Cooper M., Mogensen C., Chalmers J.
Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR.
Book
2010
Zoungas Sophia
BP management in Diabetes: Have we reached the limit? [Invited speaker]
Conference Paper
2010
Pfizer Cardiovascular Forum
Grobbee D., Cass Alan, Heerspink H., Woodward Mark, Zoungas Sophia, Mancia G., Cooper M., Mogensen C., T. Ninomiya., Chalmers J.
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
Journal Article
2010
European Heart Journal
Grobbee D., Kengne Andre, Woodward Mark, Zoungas Sophia, ADVANCE Collaborative Group Writing Committee, Marre M., Pan C., Colagiuri S., Hamet P., Heller S.
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax
Journal Article
2010
Diabetologia
de Galan Bastiaan, Kengne Andre, Zoungas Sophia, Poulter N., Pillai A., Marre M., Harrap S., Chalmers J., Billot Laurent, Neal Bruce
The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial
Journal Article
2010
Diabetes Research and Clinical Practice
Zoungas Sophia
[Keynote speaker] Strategies to prevent Contrast-induced nephropathy
Conference Paper
2010
Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand
Zoungas Sophia
Chair of session: Dementia, Depression and Diabetes
Conference Paper
2010
Annual Scientific Meeting of the Australian Diabetes Society
Li Qiang, Czernichow S., de Galan Bastiaan, Woodward Mark, Zoungas Sophia, Poulter N., Batty G., Taylor B., Chalmers J., Neal Bruce
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Journal Article
2010
Diabetologia
Teede H., Meyer C., Hutchison S., Moran L., Zoungas Sophia, McGrath B.
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy
Journal Article
2010
Fertility and Sterility
Wong J., Wright C., Teede H., Zoungas Sophia
Evidence-based guidelines for perioperative management of diabetes in cardiac and vascular surgery
Journal Article
2010
World Journal of Surgery
Zoungas Sophia
Does Glucose lowering prevent cardiovascular disease? [Invited speaker]
Conference Paper
2010
The Baker IDI & George Institute Meeting
Zoungas Sophia, Chalmers J., Patel Anushka
Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study
Journal Article
2009
US Endocrinology
Cass Alan, Navaneethan S., Kang A., Nigwekar S., Zoungas Sophia, Kulshrestha S., Strippoli G., Gallagher M., Jardine M, Perkovic Vlado
[Protocol] Interventions for lowering plasma homocysteine levels in dialysis patients
Journal Article
2009
Cochrane Database of Systematic Reviews

Sophia Zoungas's Publications

Severe hypoglycemia and risks of vascular events and death in the ADVANCE trial

Severe hypoglycemia and risks of vascular events and death

Intensive glucose control is renoprotective in type 2 diabetes

Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population

Management of chronic kidney disease in Australian general practice (the AusHEART Study)

How to read a report of a randomized controlled trial

Chronic Kidney Disease and Cardiovascular risk (Co Chair of session entitled “Bones, Hearts and Kidneys”) [Invited speaker]

Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR.

BP management in Diabetes: Have we reached the limit? [Invited speaker]

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax

The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

[Keynote speaker] Strategies to prevent Contrast-induced nephropathy

Chair of session: Dementia, Depression and Diabetes

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy

Evidence-based guidelines for perioperative management of diabetes in cardiac and vascular surgery

Does Glucose lowering prevent cardiovascular disease? [Invited speaker]

Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study

[Protocol] Interventions for lowering plasma homocysteine levels in dialysis patients

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country